No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
A Quick Look at Today's Ratings for Generation Bio(GBIO.US), With a Forecast Between $8 to $9
Generation Bio Is Maintained at Buy by Needham
Generation Bio Analyst Ratings
Cautious Optimism for Generation Bio Amid Strategic Focus and Valuation Concerns
Strategic Shift and Focus on In Vivo SiRNA Therapeutics: Generation Bio's Streamlined Path Forward
TD Cowen Sticks to Their Hold Rating for Generation Bio (GBIO)